143 related articles for article (PubMed ID: 23015513)
21. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years.
Jess T; Simonsen J; Jørgensen KT; Pedersen BV; Nielsen NM; Frisch M
Gastroenterology; 2012 Aug; 143(2):375-81.e1; quiz e13-4. PubMed ID: 22522090
[TBL] [Abstract][Full Text] [Related]
22. Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.
Meek IL; Picavet HS; Vonkeman HE; Verschuren WM; van de Laar MA
Rheumatology (Oxford); 2013 Jan; 52(1):210-6. PubMed ID: 22847678
[TBL] [Abstract][Full Text] [Related]
23. [Increased multimorbidity in patients in general practice in the period 2003-2009].
Tacken MA; Opstelten W; Vossen I; Smeele IJ; Calsbeek H; Jacobs JE; Braspenning JC
Ned Tijdschr Geneeskd; 2011; 155(26):A3109. PubMed ID: 21767421
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
25. Risk of colorectal cancer in women with pelvic inflammatory disease: a matched cohort study.
Hsu MI; Lin HW
BJOG; 2014 Feb; 121(3):337-42. PubMed ID: 24131489
[TBL] [Abstract][Full Text] [Related]
26. Screening and systematic follow-up for cardiopulmonary comorbidity in elective surgery for colorectal cancer: a randomised feasibility study.
Rahr HB; Streym S; Kryh-Jensen CG; Hougaard HT; Knudsen AS; Kristensen SH; Ejlersen E
World J Surg Oncol; 2019 Jul; 17(1):127. PubMed ID: 31331339
[TBL] [Abstract][Full Text] [Related]
27. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
[TBL] [Abstract][Full Text] [Related]
28. No increase in colorectal cancer in patients under 50 years of age: a Victorian experience from the last decade.
Sia CS; Paul E; Wale RJ; Lynch AC; Heriot AG; Warrier SK
Colorectal Dis; 2014 Sep; 16(9):690-5. PubMed ID: 24766558
[TBL] [Abstract][Full Text] [Related]
29. Risk of colorectal cancer in chronic kidney disease: a matched cohort study based on administrative data.
Wu MY; Chang TC; Chao TY; Huang MT; Lin HW
Ann Surg Oncol; 2013 Nov; 20(12):3885-91. PubMed ID: 23807660
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah.
Samadder NJ; Curtin K; Wong J; Tuohy TM; Mineau GP; Smith KR; Pimentel R; Pappas L; Boucher K; Garrido-Laguna I; Provenzale D; Burt RW
Clin Gastroenterol Hepatol; 2014 Dec; 12(12):2078-84.e1-2. PubMed ID: 24768809
[TBL] [Abstract][Full Text] [Related]
31. Comorbidity Patterns in Patients Newly Diagnosed With Colorectal Cancer: Network-Based Study.
Qiu H; Wang L; Zhou L; Wang X
JMIR Public Health Surveill; 2023 Sep; 9():e41999. PubMed ID: 37669093
[TBL] [Abstract][Full Text] [Related]
32. Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study.
Zanders MM; van Steenbergen LN; Haak HR; Rutten HJ; Pruijt JF; Poortmans PM; Lemmens VE; van de Poll-Franse LV
Diabet Med; 2013 Oct; 30(10):1181-8. PubMed ID: 23758334
[TBL] [Abstract][Full Text] [Related]
33. Multimorbidity in primary care: prevalence and trend over the last 20 years.
Uijen AA; van de Lisdonk EH
Eur J Gen Pract; 2008; 14 Suppl 1():28-32. PubMed ID: 18949641
[TBL] [Abstract][Full Text] [Related]
34. Traditional CVD risk factors and socio-economic deprivation in Roma minority population of Croatia.
Zeljko H; Skarić-Jurić T; Narancic NS; Salihović MP; Klarić IM; Barbalić M; Starcević B; Lauc LB; Janićijević B
Coll Antropol; 2008 Sep; 32(3):667-76. PubMed ID: 18982735
[TBL] [Abstract][Full Text] [Related]
35. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.
Goossens-Laan CA; Leliveld AM; Verhoeven RH; Kil PJ; de Bock GH; Hulshof MC; de Jong IJ; Coebergh JW
Int J Cancer; 2014 Aug; 135(4):905-12. PubMed ID: 24420527
[TBL] [Abstract][Full Text] [Related]
36. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
AIRTUM Working Group
Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease.
Manninen P; Karvonen AL; Laukkarinen J; Aitola P; Huhtala H; Collin P
Scand J Gastroenterol; 2015 Apr; 50(4):423-8. PubMed ID: 25636976
[TBL] [Abstract][Full Text] [Related]
38. Trends in incidence, treatment and survival of patients with stage IV colorectal cancer: a population-based series.
van der Pool AE; Damhuis RA; Ijzermans JN; de Wilt JH; Eggermont AM; Kranse R; Verhoef C
Colorectal Dis; 2012 Jan; 14(1):56-61. PubMed ID: 21176063
[TBL] [Abstract][Full Text] [Related]
39. Unresolved Pain Interference among Colorectal Cancer Survivors: Implications for Patient Care and Outcomes.
Kenzik K; Pisu M; Johns SA; Baker T; Oster RA; Kvale E; Fouad MN; Martin MY
Pain Med; 2015 Jul; 16(7):1410-25. PubMed ID: 25799885
[TBL] [Abstract][Full Text] [Related]
40. Influence of comorbidity and age on 1-, 2-, and 3-month postoperative mortality rates in gastrointestinal cancer patients.
van Gestel YR; Lemmens VE; de Hingh IH; Steevens J; Rutten HJ; Nieuwenhuijzen GA; van Dam RM; Siersema PD
Ann Surg Oncol; 2013 Feb; 20(2):371-80. PubMed ID: 22987098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
